Literature DB >> 19208298

Strongyloides hyperinfection syndrome in British veterans.

D Robson1, N J Beeching, G V Gill.   

Abstract

Strongyloides hyperinfection syndrome is a rare but serious and often fatal complication of strongyloidiasis, usually precipitated by immune suppression (frequently caused by corticosteroidal drugs). Infections with Strongyloides stercoralis are known to occur in British veterans who served in South-east Asia during the Second World War, particularly in those held as prisoners of war by the Japanese. No information on the frequency of disseminated strongyloidiasis in these men is, however, available. A multi-source enquiry designed to detect the cases of Strongyloides hyperinfection syndrome that occurred, in the U.K., in the 60 years following the end of the Second World War was therefore initiated. The relevant data were collected from death certificates, searches of the medical literature, enquiries with veterans' organizations, and questionnaires sent to all the units of infectious and tropical disease in the U.K.. Overall, 25 cases of hyperinfection in the U.K. were detected but only two involved veterans of the Second World War (one British ex-Far East prisoner of war and a British former soldier who had been involved with the evacuation of Singapore in 1945). Although the risk of hyperinfection in veterans appears small, information from the literature and veterans' organizations indicates that there are still probably 300-400 such veterans who remain alive in Britain and have Strongyloides infections. Attempts at the detection and eradication of the infections in the surviving veterans are recommended.

Entities:  

Mesh:

Year:  2009        PMID: 19208298     DOI: 10.1179/136485909X385009

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  5 in total

1.  Methylprednisolone acetate induces, and Δ7-dafachronic acid suppresses, Strongyloides stercoralis hyperinfection in NSG mice.

Authors:  John B Patton; Sandra Bonne-Année; Jessica Deckman; Jessica A Hess; April Torigian; Thomas J Nolan; Zhu Wang; Steven A Kliewer; Amy C Durham; James J Lee; Mark L Eberhard; David J Mangelsdorf; James B Lok; David Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

2.  Strongyloidiasis-related deaths in the United States, 1991-2006.

Authors:  Curtis Croker; Roshan Reporter; Matt Redelings; Laurene Mascola
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Strongyloidiasis in man 75 years after initial exposure.

Authors:  Virginie Prendki; Pierre Fenaux; Rémy Durand; Marc Thellier; Olivier Bouchaud
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

4.  Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection.

Authors:  Fatehi Elnour Elzein; Mohammed Alsaeed; Sulafa Ballool; Ashraf Attia
Journal:  Case Rep Transplant       Date:  2016-09-15

5.  Management of severe strongyloidiasis attended at reference centers in Spain.

Authors:  Angela Martinez-Perez; Silvia Roure Díez; Moncef Belhassen-Garcia; Diego Torrús-Tendero; Jose Luis Perez-Arellano; Teresa Cabezas; Cristina Soler; Marta Díaz-Menéndez; Miriam Navarro; Begoña Treviño; Fernando Salvador
Journal:  PLoS Negl Trop Dis       Date:  2018-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.